ArticleCancer chemotherapy and pharmacology2024

Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer.

Khushboo A Gandhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.